Relationship between residual gastric content and peri-operative semaglutide use assessed by gastric ultrasound: a prospective observational study
In addition, because the demonstration will operate outside the Part D benefit, the manufacturers wont be responsible for providing the manufacturer price discount on eligible GLP-1s (10% in the Part D initial benefit phase and 20% in the catastrophic phase.) While many prior section 402 demonstrations have had to conform to budget neutrality rules by the Office of Management and Budget (OMB), some demonstrations have been able to move forward without this requirement
Given the importance of adequate nutrition before, during, and after GLP-1 use, clinicians and individuals must be equipped with knowledge and skills around healthy eating
Thats where Orforglipron comes in
The 4mg tier is also the lowest maintenance dose being tested in the Phase 3 TRIUMPH program, which signals that the sponsor considers it the minimum effective dose for a regulatory filing
Strength training: Get stronger, leaner, healthier
